JP2023519868A5 - - Google Patents

Info

Publication number
JP2023519868A5
JP2023519868A5 JP2022558271A JP2022558271A JP2023519868A5 JP 2023519868 A5 JP2023519868 A5 JP 2023519868A5 JP 2022558271 A JP2022558271 A JP 2022558271A JP 2022558271 A JP2022558271 A JP 2022558271A JP 2023519868 A5 JP2023519868 A5 JP 2023519868A5
Authority
JP
Japan
Application number
JP2022558271A
Other languages
Japanese (ja)
Other versions
JP7738007B2 (ja
JP2023519868A (ja
JPWO2021195503A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/024370 external-priority patent/WO2021195503A1/en
Publication of JP2023519868A publication Critical patent/JP2023519868A/ja
Publication of JPWO2021195503A5 publication Critical patent/JPWO2021195503A5/ja
Publication of JP2023519868A5 publication Critical patent/JP2023519868A5/ja
Priority to JP2025144528A priority Critical patent/JP2025172113A/ja
Application granted granted Critical
Publication of JP7738007B2 publication Critical patent/JP7738007B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022558271A 2020-03-27 2021-03-26 T細胞受容体 Active JP7738007B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025144528A JP2025172113A (ja) 2020-03-27 2025-09-01 T細胞受容体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063000800P 2020-03-27 2020-03-27
US63/000,800 2020-03-27
PCT/US2021/024370 WO2021195503A1 (en) 2020-03-27 2021-03-26 T cell receptors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025144528A Division JP2025172113A (ja) 2020-03-27 2025-09-01 T細胞受容体

Publications (4)

Publication Number Publication Date
JP2023519868A JP2023519868A (ja) 2023-05-15
JPWO2021195503A5 JPWO2021195503A5 (https=) 2024-04-05
JP2023519868A5 true JP2023519868A5 (https=) 2024-04-05
JP7738007B2 JP7738007B2 (ja) 2025-09-11

Family

ID=77890524

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022558271A Active JP7738007B2 (ja) 2020-03-27 2021-03-26 T細胞受容体
JP2025144528A Pending JP2025172113A (ja) 2020-03-27 2025-09-01 T細胞受容体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025144528A Pending JP2025172113A (ja) 2020-03-27 2025-09-01 T細胞受容体

Country Status (11)

Country Link
US (1) US20230124640A1 (https=)
EP (1) EP4126924A4 (https=)
JP (2) JP7738007B2 (https=)
KR (1) KR20220160040A (https=)
CN (1) CN115485294A (https=)
AU (1) AU2021244594A1 (https=)
BR (1) BR112022019380A2 (https=)
CA (1) CA3177181A1 (https=)
IL (1) IL296827A (https=)
MX (1) MX2022012062A (https=)
WO (1) WO2021195503A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3225252A1 (en) 2021-07-14 2023-01-19 Jordan JARJOUR Engineered t cell receptors fused to binding domains from antibodies
CN119546328A (zh) 2022-04-08 2025-02-28 再生元制药公司 多部分受体和信号传导复合物
CN117003855B (zh) * 2023-09-20 2024-02-23 广州市老人院 一种t细胞受体及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8361794B2 (en) * 2004-06-29 2013-01-29 Immunocore Limited Cells expressing a modified T cell receptor
LT3424947T (lt) * 2011-10-28 2021-03-10 Regeneron Pharmaceuticals, Inc. Genetiškai modifikuotos t ląstelių receptorių pelės
CN102876715B (zh) 2012-09-05 2014-07-23 南方医科大学 一种用于结核/hiv共感染基因治疗的逆转录病毒载体及其应用
CN102911267B (zh) 2012-09-19 2014-04-02 南方医科大学 一种结核/hiv抗原肽双特异性tcr、其重组逆转录病毒载体与应用
EP3472208B9 (en) 2016-06-17 2023-10-04 Medigene Immunotherapies GmbH T cell receptors and uses thereof
CN110352068A (zh) * 2016-12-02 2019-10-18 南加利福尼亚大学 合成的免疫受体及其使用方法
BR112020006643A2 (pt) * 2017-10-03 2020-09-24 Juno Therapeutics Inc moléculas de ligação específica ao hpv
EP3714941A1 (en) 2019-03-27 2020-09-30 Medigene Immunotherapies GmbH Mage-a4 tcrs
KR20220030933A (ko) 2019-05-08 2022-03-11 메디진 이뮤노테라피스 게엠바하 조작된 t 세포
CA3225252A1 (en) * 2021-07-14 2023-01-19 Jordan JARJOUR Engineered t cell receptors fused to binding domains from antibodies

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
JP2023519868A5 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021014044A2 (https=)
BR102021012571A2 (https=)